Rebecca J. Fairclough, Matthew J. Wood and Kay E. Davies are at the Department of Physiology, Anatomy and Genetics, University of Oxford, Parks Road, Oxford OX1 3PT, UK.
Rebecca J. Fairclough and Kay E. Davies are also at the MRC Functional Genomics Unit, MRC Functional Genomics Unit, Department of Physiology, Anatomy and Genetics, Parks Road, Oxford OX1 3PT, UK.
Competing interests statement
Kay E. Davies is on the scientific advisory board of Prosensa plc and Summit plc. Rebecca J. Fairclough and Matthew J. Wood declare no competing financial interests.
Rebecca J. Fairclough
Rebecca J. Fairclough works on developing therapeutic approaches for Duchenne muscular dystrophy in Kay Davies' laboratory at the University of Oxford, UK. Her research interests focus on understanding the molecular basis of genetic disorders for translation into effective therapies. She has experience working in translational research in academia, technology transfer and global pharmaceutical environments spanning a broad range of disease areas.
Matthew J. Wood
Matthew J. Wood is Professor of Neuroscience in the Department of Physiology, Anatomy and Genetics at the University of Oxford, UK. His primary research interest is in the field of RNA biology, the study of extracellular RNA and the development of RNA-based therapeutics for degenerative disorders of the nervous system and muscle. He is currently co-principal investigator of the International MDEX Consortium, which is developing RNA-based oligonucleotide therapies for Duchenne's muscular dystrophy.
Kay E. Davies
Kay E. Davies is Dr Lee's Professor of Anatomy and Director of the UK Medical Research Council Functional Genomics Unit at the University of Oxford, UK. Her research is focused on the understanding of muscle disease, movement and behavioural disorders. Her group has developed various genetic models to understand disease pathogenesis as well as to develop effective treatments. Studies range from the analysis of single gene defects, such as Duchenne muscular dystrophy, to the use of genetic models that provide insights into the understanding of neurodegenerative diseases, as well as mental impairment and schizophrenia.